Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityNotes PayablesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

1606 (CBDW) Cash & Equivalents (2021 - 2025)

1606 (CBDW) has disclosed Cash & Equivalents for 5 consecutive years, with $998.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 96.27% to $998.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $998.0, a 96.27% decrease, with the full-year FY2024 number at $2078.0, down 95.75% from a year prior.
  • Cash & Equivalents was $998.0 for Q3 2025 at 1606, down from $1863.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $220111.0 in Q1 2023 to a low of $285.0 in Q1 2025.
  • A 5-year average of $33323.3 and a median of $15871.0 in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 2441.11% in 2023, then plummeted 98.2% in 2025.
  • 1606's Cash & Equivalents stood at $9543.0 in 2021, then skyrocketed by 1000.96% to $105065.0 in 2022, then plummeted by 53.42% to $48941.0 in 2023, then tumbled by 95.75% to $2078.0 in 2024, then tumbled by 51.97% to $998.0 in 2025.
  • Per Business Quant, the three most recent readings for CBDW's Cash & Equivalents are $998.0 (Q3 2025), $1863.0 (Q2 2025), and $285.0 (Q1 2025).